Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug delivery
Biotech
Biogen inks $85M Alcyone buyout to acquire drug delivery tech
Biogen has given Alcyone a starring role in its drug delivery strategy, paying $85 million to snag an implant for accessing the spinal canal.
Nick Paul Taylor
Sep 18, 2025 10:30am
Denali Alzheimer's antibody clears plaques without ARIA in mice
Aug 7, 2025 2:00pm
Boehringer pens $1B pact to reduce eye drug injections
Jul 28, 2025 8:48am
Daiichi taps Nosis to deliver RNA therapies beyond the liver
Mar 11, 2025 10:24am
Novo bets up to $354M per target on Gensaic’s delivery tech
Mar 3, 2025 8:37am
Oncology biotech licenses Genevant tech for up to $123M
Dec 20, 2024 6:00am
